Although molecular mechanisms are unclear, some target genes have been investigated and linked to reduction of E-cadherin and ESCC progression, such as p21 and cyclooxygenase-2 (COX-2) [112]. Here, CDH1 is linked to esophageal squamous cell carcinoma.